Cargando…
Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer
TP53 mutations are associated with tumour progression, resistance to therapy and poor prognosis. However, in breast cancer, TP53′s overall mutation frequency is lower than expected (~25%), suggesting that other mechanisms may be responsible for the disruption of this critical tumour suppressor. p53...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223648/ https://www.ncbi.nlm.nih.gov/pubmed/35743117 http://dx.doi.org/10.3390/ijms23126670 |